MACRA Regulatory Reforms | ASCRS

MACRA Regulatory Reform

Our Position 

ASCRS supports the goals of the Medicare Access and CHIP Reauthorization Act (MACRA) and continues to monitor CMS’ implementation to ensure its intent is fully realized and preserved. ASCRS strongly opposes certain provisions of the 2020 Medicare Physician Fee Schedule (MPFS) final rule pertaining to the Quality Payment Program (QPP), including potentially making its new  participation pathway for 2021, the Merit-Based Incentive Payment System (MIPS) Value Pathways (MVPs) mandatory, inclusion of FDA-approved pass-through drugs in the cataract surgery episode-based cost measure, and removing “topped-out” ophthalmology measures. 

Issue Brief

How it Impacts You

Ophthalmologists have some of the highest rates of participation in the MIPS programs across medicine. ASCRS is advocating to ensure that all ophthalmology practices can participate successfully in the program by reporting on clinically-relevant measures and activities. 

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.